Natural killer cell activity in schizophrenia and schizoaffective disorder: a pilot study.
Natural killer cell activity was prospectively studied in 15 patients with chronic schizophrenia and in seven patients with schizoaffective disorder, depressed type. These patients were compared to individually matched normal controls. No mean differences in natural killer cell activity between the patient groups and their controls were observed.
McDaniel
J S
JS
Department of Psychiatry, Emory University School of Medicine, Atlanta, GA 30322.
Jewart
R D
RD
Eccard
M B
MB
Pollard
W E
WE
Caudle
J
J
Stipetic
M
M
Risby
E D
ED
Lewine
R
R
Risch
S C
SC
D000328:Adult; D003602:Cytotoxicity, Immunologic / Q000276:immunology; D003866:Depressive Disorder / Q000276:immunology; D004298:Dopamine / Q000502:physiology; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D010865:Pilot Projects; D011446:Prospective Studies; D011618:Psychotic Disorders / Q000276:immunology*; D012559:Schizophrenia / Q000276:immunology*
D004298:Dopamine